Annual SGA
$307.98 M
+$27.81 M+9.93%
December 31, 2024
Summary
- As of March 15, 2025, ASND annual SGA is $307.98 million, with the most recent change of +$27.81 million (+9.93%) on December 31, 2024.
- During the last 3 years, ASND annual SGA has risen by +$118.46 million (+62.50%).
- ASND annual SGA is now at all-time high.
Performance
ASND SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$83.98 M
+$9.05 M+12.08%
December 31, 2024
Summary
- As of March 15, 2025, ASND quarterly SGA is $83.98 million, with the most recent change of +$9.05 million (+12.08%) on December 31, 2024.
- Over the past year, ASND quarterly SGA has increased by +$3.96 million (+4.95%).
- ASND quarterly SGA is now at all-time high.
Performance
ASND Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
N/A
December 31, 2024
Summary
- ASND TTM SGA is not available.
Performance
ASND TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ASND Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +9.9% | +5.0% | - |
3 y3 years | +62.5% | +5.0% | - |
5 y5 years | +467.5% | +5.0% | - |
ASND Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +62.5% | at high | +60.5% | ||
5 y | 5-year | at high | +467.5% | at high | +344.1% | ||
alltime | all time | at high | +9498.2% | at high | >+9999.0% |
Ascendis Pharma A/S Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $307.98 M(+9.9%) | $83.98 M(+12.1%) | $311.46 M(+5.8%) |
Sep 2024 | - | $74.93 M(-6.4%) | $294.39 M(+2.4%) |
Jun 2024 | - | $80.02 M(+10.3%) | $287.52 M(+1.2%) |
Mar 2024 | - | $72.54 M(+8.4%) | $284.14 M(+0.4%) |
Dec 2023 | $280.17 M(+23.1%) | $66.90 M(-1.7%) | $283.07 M(+5.4%) |
Sep 2023 | - | $68.06 M(-11.2%) | $268.49 M(+2.7%) |
Jun 2023 | - | $76.64 M(+7.2%) | $261.55 M(+6.7%) |
Mar 2023 | - | $71.47 M(+36.6%) | $245.18 M(+8.0%) |
Dec 2022 | $227.63 M(+20.1%) | $52.33 M(-14.4%) | $226.93 M(-1.3%) |
Sep 2022 | - | $61.12 M(+1.4%) | $229.84 M(+6.9%) |
Jun 2022 | - | $60.27 M(+13.3%) | $215.04 M(+9.0%) |
Mar 2022 | - | $53.21 M(-3.7%) | $197.37 M(+4.4%) |
Dec 2021 | $189.52 M(+116.5%) | $55.25 M(+19.3%) | $189.04 M(+19.5%) |
Sep 2021 | - | $46.32 M(+8.7%) | $158.15 M(+19.5%) |
Jun 2021 | - | $42.60 M(-5.1%) | $132.33 M(+17.5%) |
Mar 2021 | - | $44.88 M(+84.3%) | $112.64 M(+28.7%) |
Dec 2020 | $87.56 M(+61.4%) | $24.35 M(+18.8%) | $87.53 M(+6.6%) |
Sep 2020 | - | $20.49 M(-10.6%) | $82.08 M(+12.9%) |
Jun 2020 | - | $22.91 M(+15.9%) | $72.71 M(+17.1%) |
Mar 2020 | - | $19.77 M(+4.5%) | $62.11 M(+14.6%) |
Dec 2019 | $54.27 M | $18.91 M(+70.1%) | $54.20 M(+20.9%) |
Sep 2019 | - | $11.12 M(-9.7%) | $44.84 M(+7.7%) |
Jun 2019 | - | $12.31 M(+3.9%) | $41.62 M(+17.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2019 | - | $11.85 M(+24.1%) | $35.55 M(+20.8%) |
Dec 2018 | $29.59 M(+93.8%) | $9.55 M(+20.9%) | $29.42 M(+19.2%) |
Sep 2018 | - | $7.90 M(+26.6%) | $24.68 M(+22.7%) |
Jun 2018 | - | $6.24 M(+9.0%) | $20.12 M(+15.4%) |
Mar 2018 | - | $5.73 M(+19.0%) | $17.43 M(+14.3%) |
Dec 2017 | $15.27 M(+19.9%) | $4.81 M(+44.1%) | $15.25 M(+9.1%) |
Sep 2017 | - | $3.34 M(-6.1%) | $13.98 M(+2.9%) |
Jun 2017 | - | $3.56 M(+0.4%) | $13.59 M(+4.1%) |
Mar 2017 | - | $3.54 M(-0.1%) | $13.05 M(+2.6%) |
Dec 2016 | $12.73 M(+21.9%) | $3.54 M(+20.3%) | $12.72 M(-1.9%) |
Sep 2016 | - | $2.95 M(-2.2%) | $12.97 M(+12.1%) |
Jun 2016 | - | $3.02 M(-6.0%) | $11.57 M(+5.9%) |
Mar 2016 | - | $3.21 M(-15.5%) | $10.93 M(+4.7%) |
Dec 2015 | $10.45 M(+25.2%) | $3.80 M(+144.7%) | $10.43 M(+8.8%) |
Sep 2015 | - | $1.55 M(-34.5%) | $9.59 M(-5.1%) |
Jun 2015 | - | $2.37 M(-12.7%) | $10.10 M(+4.5%) |
Mar 2015 | - | $2.71 M(-8.2%) | $9.66 M(+17.2%) |
Dec 2014 | $8.34 M(+160.0%) | $2.95 M(+43.3%) | $8.24 M(+36.5%) |
Sep 2014 | - | $2.06 M(+6.9%) | $6.04 M(+51.9%) |
Jun 2014 | - | $1.93 M(+49.1%) | $3.98 M(+94.3%) |
Mar 2014 | - | $1.29 M(+72.3%) | $2.05 M(+172.3%) |
Dec 2013 | $3.21 M(-7.2%) | $751.40 K | $751.40 K |
Dec 2012 | $3.46 M | - | - |
FAQ
- What is Ascendis Pharma A/S annual SGA?
- What is the all time high annual SGA for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual SGA year-on-year change?
- What is Ascendis Pharma A/S quarterly SGA?
- What is the all time high quarterly SGA for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly SGA year-on-year change?
- What is the all time high TTM SGA for Ascendis Pharma A/S?
What is Ascendis Pharma A/S annual SGA?
The current annual SGA of ASND is $307.98 M
What is the all time high annual SGA for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual SGA is $307.98 M
What is Ascendis Pharma A/S annual SGA year-on-year change?
Over the past year, ASND annual SGA has changed by +$27.81 M (+9.93%)
What is Ascendis Pharma A/S quarterly SGA?
The current quarterly SGA of ASND is $83.98 M
What is the all time high quarterly SGA for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly SGA is $83.98 M
What is Ascendis Pharma A/S quarterly SGA year-on-year change?
Over the past year, ASND quarterly SGA has changed by +$3.96 M (+4.95%)
What is the all time high TTM SGA for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM SGA is $556.61 M